PRAC

E553849

PRAC is a committee within the European Medicines Agency responsible for assessing and monitoring the safety of human medicines.

All labels observed (1)

Label Occurrences
PRAC canonical 2

How this entity was disambiguated

Statements (45)

Predicate Object
instanceOf pharmacovigilance committee
abbreviationOf Pharmacovigilance Risk Assessment Committee NERFINISHED
aim to protect public health by ensuring the safe use of medicines
composition independent scientific experts
members nominated by EEA-EFTA states
members nominated by EU Member States
representatives of healthcare professionals
representatives of patients and consumers
country Netherlands
dateFormed 2012
field drug safety
pharmacovigilance
public health
formedAs new committee under the 2010 EU pharmacovigilance legislation
fullName Pharmacovigilance Risk Assessment Committee NERFINISHED
hasRole advisory body to the European Medicines Agency Management Board
providing scientific opinions on safety issues
jurisdiction European Union
language English
locatedIn Amsterdam
Netherlands
meets monthly
parentOrganization European Medicines Agency NERFINISHED
partOf European Medicines Agency NERFINISHED
produces meeting highlights
recommendations on safety-related variations and suspensions
regulatoryFramework Directive 2001/83/EC as amended by pharmacovigilance legislation NERFINISHED
EU pharmacovigilance legislation
Regulation (EC) No 726/2004 NERFINISHED
responsibleFor assessing the safety of human medicines
monitoring the safety of human medicines
periodic safety update report assessment
pharmacovigilance activities in the EU
pharmacovigilance inspections guidance
post-authorisation safety studies assessment
providing recommendations on safety-related regulatory actions
recommending risk minimisation measures for medicines
risk assessment of adverse drug reactions
safety-related aspects of risk management plans
signal detection and evaluation for medicinal products
scope human medicines
website https://www.ema.europa.eu/en/committees/pharmacovigilance-risk-assessment-committee-prac
worksWith Committee for Medicinal Products for Human Use NERFINISHED
Coordination Group for Mutual Recognition and Decentralised Procedures – Human NERFINISHED
national competent authorities for medicines in EU and EEA

How these facts were elicited

Referenced by (2)

Full triples — surface form annotated when it differs from this entity's canonical label.